Application no. and date | 16775424.1 (espacenet) (Federated) (European Patent Register), 20160921 | Patent/reg. no. and date | DK/EP 3352735, 20230830 | Publication date | 20180801 | Priority no. and date | US 201562221290 P, 20150921 | EP pub. no. and date |
EP 3352735 20180801 | Effective date | | Applicant/owner | Teva Pharmaceuticals International GmbH, Schlüsselstrasse 12
8645 Jona, CH | Applicant ref. no. | 1679174 | Inventor | SMITH, Mark, Alan, 11 Gomer Court
Elkton, MD 21921, US, CLAASSEN-PUNT, Carine, Vuurbloem 34
2317 LP Leiden, NL | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/551 (2006.01) , A61K 47/34 (2017.01) , A61K 9/00 (2006.01) , A61K 9/16 (2006.01) , A61P 25/00 (2006.01) , A61P 25/18 (2006.01) | Title | OLANZAPINFORMULERINGER MED LANGVARIG FRIGIVELSE | Int. application no. | US2016052757 | Int. publication no. | WO2017053346 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|